Therapy Watch launches a new global Lupus tracker

November 17, 2020

Therapy Watch has launched a new tracker for Lupus. This multi country study will report on patients with systemic lupus erythematosus (SLE) and lupus nephritis (LN) across core global markets.

shutterstock_1164945673- Lupus-hand

Lupus is an almost invisible disease, yet can have considerable impact on a person’s quality of life, and there is much that pharma can do to help. The reasons for this autoimmune malfunction remain elusive, although genetic and environmental factors may play a part. Prevalence has been estimated at around 2-140 per 100,000 population worldwide, although it could be as high as 207 per 100,000. Women of childbearing age are around nine times more likely to have lupus than men of equivalent age.

This tracker will help our clients address such questions as understanding the dynamics of the market, including initiation and maintenance therapy choice, drivers for prescribing, patient demographics, market shares, treatment patterns and source of business.

Therapy Watch is a syndicated market tracking tool that provides marketing teams, brand managers and market researchers with strategic and tactical market information. Run entirely online to ensure speed, quality and up-to-date access to the very latest market data,
Therapy Watch offers a clear advantage by putting you in closer contact with your market than ever before.

Sample HubSpot User

Sample HubSpot User

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using 'Content here, content here', making it look like readable English.

Get our newsletter direct to your inbox.

Sign up to receive Rapport

Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research.

Sign up here